Wu H - Search Results

1

Hepatic interferon regulatory factor 8 expression mediates liver ischemia/reperfusion injury in mice.

Shi G, Zhang Z, Ma S, Li Y, Du S, Chu Y, Li Y, Tang X, Yang Y, Chen Z, Wang Z, Wu H. Shi G, et al. Among authors: wu h. Biochem Pharmacol. 2021 Oct;192:114728. doi: 10.1016/j.bcp.2021.114728. Epub 2021 Aug 13. Biochem Pharmacol. 2021. PMID: 34400126

2

Combination of sorafenib and enzalutamide as a potential new approach for the treatment of castration-resistant prostate cancer.

Wu H, Zhang L, Gao X, Zhang X, Duan J, You L, Cheng Y, Bian J, Zhu Q, Yang Y. Wu H, et al. Cancer Lett. 2017 Jan 28;385:108-116. doi: 10.1016/j.canlet.2016.10.036. Epub 2016 Nov 1. Cancer Lett. 2017. PMID: 27815035

3

SHC004-221A1, a novel tyrosine kinase, potently inhibits T315I mutant BCR-ABL in chronic myeloid leukemia.

Wang D, Zheng Y, Li J, Wu H, Li X, Tang Y, Liu Y, Li J, Sun R, Zhou Y, Sun J, Yang Y. Wang D, et al. Among authors: wu h. Eur J Pharmacol. 2017 Sep 15;811:117-124. doi: 10.1016/j.ejphar.2017.06.001. Epub 2017 Jun 6. Eur J Pharmacol. 2017. PMID: 28595903

4

Depression promotes prostate cancer invasion and metastasis via a sympathetic-cAMP-FAK signaling pathway.

Cheng Y, Gao XH, Li XJ, Cao QH, Zhao DD, Zhou JR, Wu HX, Wang Y, You LJ, Yang HB, He YL, Li YR, Bian JS, Zhu QY, Birnbaumer L, Yang Y. Cheng Y, et al. Oncogene. 2018 May;37(22):2953-2966. doi: 10.1038/s41388-018-0177-4. Epub 2018 Mar 8. Oncogene. 2018. PMID: 29515233 Free PMC article.

5

Depression-Induced Neuropeptide Y Secretion Promotes Prostate Cancer Growth by Recruiting Myeloid Cells.

Cheng Y, Tang XY, Li YX, Zhao DD, Cao QH, Wu HX, Yang HB, Hao K, Yang Y. Cheng Y, et al. Clin Cancer Res. 2019 Apr 15;25(8):2621-2632. doi: 10.1158/1078-0432.CCR-18-2912. Epub 2018 Nov 30. Clin Cancer Res. 2019. PMID: 30504424

6

In vitro and in vivo evidence that quercetin protects against diabetes and its complications: A systematic review of the literature.

Shi GJ, Li Y, Cao QH, Wu HX, Tang XY, Gao XH, Yu JQ, Chen Z, Yang Y. Shi GJ, et al. Biomed Pharmacother. 2019 Jan;109:1085-1099. doi: 10.1016/j.biopha.2018.10.130. Epub 2018 Nov 6. Biomed Pharmacother. 2019. PMID: 30551359 Free article.

7

Discovery of pyridine tetrahydroisoquinoline thiohydantoin derivatives with low blood-brain barrier penetration as the androgen receptor antagonists.

Xu X, Du Q, Meng Y, Li Z, Wu H, Li Y, Zhao Z, Ge R, Lu X, Xue S, Chen X, Yang Y, Wang J, Bian J. Xu X, et al. Among authors: wu h. Eur J Med Chem. 2020 Apr 15;192:112196. doi: 10.1016/j.ejmech.2020.112196. Epub 2020 Mar 5. Eur J Med Chem. 2020. PMID: 32169785

8

Loss of a Negative Feedback Loop between IRF8 and AR Promotes Prostate Cancer Growth and Enzalutamide Resistance.

Wu H, You L, Li Y, Zhao Z, Shi G, Chen Z, Wang Z, Li X, Du S, Ye W, Gao X, Duan J, Cheng Y, Tao W, Bian J, Zhou JR, Zhu Q, Yang Y. Wu H, et al. Cancer Res. 2020 Jul 1;80(13):2927-2939. doi: 10.1158/0008-5472.CAN-19-2549. Epub 2020 Apr 27. Cancer Res. 2020. PMID: 32341037 Free PMC article.

9

Hypoxia-induced myeloid derived growth factor promotes hepatocellular carcinoma progression through remodeling tumor microenvironment.

Wang X, Mao J, Zhou T, Chen X, Tu H, Ma J, Li Y, Ding Y, Yang Y, Wu H, Tang X. Wang X, et al. Among authors: wu h. Theranostics. 2021 Jan 1;11(1):209-221. doi: 10.7150/thno.49327. eCollection 2021. Theranostics. 2021. PMID: 33391471 Free PMC article.

10

Identification of novel androgen receptor degrading agents to treat advanced prostate cancer.

Wu H, Ren J, Zhao L, Li Z, Ye W, Yang Y, Wang J, Bian J. Wu H, et al. Eur J Med Chem. 2021 May 5;217:113376. doi: 10.1016/j.ejmech.2021.113376. Epub 2021 Mar 16. Eur J Med Chem. 2021. PMID: 33756125

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46,309 results

Search Page

Filters